Form 13-F position report

EVOLENT HEALTH INC

Reported by Hood River Capital Management LLC

EVH CUSIP 30050B101 Manager CIK 0001578177

Reported 2,207,037 shares, up 137,004 (6.6%) from the prior quarter.

Reported value 5.8%; share count 6.6% vs. the prior quarter.

Added
% of reported 13F value 1.61% This manager · Q1 2024
Shares 2,207,037 Quarter-end amount reported
Reported value $72,368,743 Fair value at quarter end
Consecutive quarters held 8 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-06-30 16854000
2022-09-30 20466000
2022-12-31 22421880
2023-03-31 27057000
2023-06-30 25581000
2023-09-30 51944275
2023-12-31 68373190
2024-03-31 72368743
2024-06-30 30925682
2024-09-30 36548478
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for EVOLENT HEALTH INC held by Hood River Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -1,292,379 (-100.0%) 0 $0 2025-02-14
Q3 2024 Reduced 1,292,379 -325,073 (-20.1%) 0.59% $36,548,478 2024-11-14
Q2 2024 Reduced 1,617,452 -589,585 (-26.7%) 0.64% $30,925,682 2024-08-14
Q1 2024 Added 2,207,037 +137,004 (6.6%) 1.61% $72,368,743 2024-05-15
Q4 2023 Added 2,070,033 +162,421 (8.5%) 1.88% $68,373,190 2024-02-14
Q3 2023 Added 1,907,612 +1,063,363 (126.0%) 1.67% $51,944,275 2023-11-14
Q2 2023 Added 844,249 +10,448 (1.3%) 0.76% $25,581,000 2023-08-14
Q1 2023 Added 833,801 +35,301 (4.4%) 0.88% $27,057,000 2023-05-15
Q4 2022 Added 798,500 +228,906 (40.2%) 0.81% $22,421,880 2023-02-14
Q3 2022 Added 569,594 +20,798 (3.8%) 0.78% $20,466,000 2022-11-14
Q2 2022 New 548,796 +548,796 (0.0%) 0.67% $16,854,000 2022-08-15

Who else reported the position

275 managers reported EVOLENT HEALTH INC for Q1 2024.

Managers reporting EVOLENT HEALTH INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 10,915,070 +93,739 < 0.01% $357,905,145 36 qtrs
FMR LLC Reduced 10,592,234 -2,298,495 0.02% $347,319,354 13 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 8,853,631 +540,474 0.05% $290,310,560 8 qtrs
BlackRock Inc Reduced 8,295,382 -129,420 < 0.01% $272,005,576 33 qtrs
RA CAPITAL MANAGEMENT L P Added 5,736,132 +3,187,000 2.39% $188,087,768 3 qtrs
JPMorgan Chase & Co Reduced 4,747,107 -1,170,577 0.01% $155,657,640 36 qtrs
Rock Springs Capital Management LP Added 3,987,500 +27,500 3.32% $130,750,125 13 qtrs
WILLIAM BLAIR INVESTMENT MANAGEMENT LLC Reduced 3,717,667 -60,786 0.32% $121,902,301 4 qtrs
BLAIR WILLIAM & CO IL Added 3,269,219 +229,062 0.34% $107,197,691 33 qtrs
Engaged Capital LLC Unchanged 3,261,458 0 17.33% $106,943,208 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COMMON STOCKS

Voting authority reported

Sole
2,096,337
Shared
0
None
110,700

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.